METABOLIC SYNDROME AND INFLAMMATION

被引:0
作者
Soto Gonzalez, Alfonso [1 ]
Bellido Guerrero, Diego [1 ]
Buno Soto, Manuela [1 ]
Pertega Diaz, Sonia [2 ]
Martinez del Olmo, Miguel [3 ]
Vidal, Ovidio [1 ]
机构
[1] Hosp Juan Canalejo, Serv Endocrinol & Nutr, La Coruna, Spain
[2] Hosp Juan Canalejo, Unidad Epidemioa Clin & Estadist, La Coruna, Spain
[3] Hosp Mexoeiro, Vigo, Pontevedra, Spain
来源
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS | 2006年 / 18卷 / 03期
关键词
Metabolic syndrome; Inflammation; High sensible C reactive protein; Ferritin;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction. Patients with metabolic syndrome (MS) have an increased risk to have atherosclerosis and cardiovascular disease. Inflammation plays a crucial role in the atherosclerosis process. Some studies, even few, have shown the relationship between high levels of ferritin, with each component of the MS. Material and methods. We studied 598 patients with overweight or obesity. We evaluated: the body composition and analytical parameters: glucose, cholesterol, triglycerides, high-density cholesterol and ferritin. Insulin resistance (IR) was defined by HOMA method. ATP III criteria were used to define MS. Results. Higher levels of triglycerides have significant more elevated levels of ferritin (124.6 ng/ml versus 65.0 ng/ml; p = .001) or glucose (105.9 ng/ml versus 78.6 ng/ml; p = .023). The number of components of the MS increases with the values of ferritin. Patients with IR have higher values of ferritin (119.27 ng/ml versus 79.05 ng/ml; p = .001), with an area under the ROC curve of 0.678. Conclusions. An Inflammatory parameter as ferritin could be useful and a precocious marker to evaluate chronic subclinic inflammatory process in daily medical practice.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 40 条
[1]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[2]   IRON OVERLOAD AUGMENTS THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN RABBITS [J].
ARAUJO, JA ;
ROMANO, EL ;
BRITO, BE ;
PARTHE, V ;
ROMANO, M ;
BRACHO, M ;
MONTANO, RF ;
CARDIER, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1172-1180
[3]   QUANTITATIVE ASPECTS OF THE REACTION BETWEEN INSULIN AND INSULIN-BINDING ANTIBODY [J].
BERSON, SA ;
YALOW, RS .
JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (11) :1996-2016
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]  
DAVIS RJ, 1986, J BIOL CHEM, V261, P8708
[6]   Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models [J].
den Boer, M ;
Voshol, PJ ;
Kuipers, F ;
Havekes, LM ;
Romijn, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :644-649
[7]   Iron stores, blood donation, and insulin sensitivity and secretion [J].
Fernández-Real, JM ;
López-Bermejo, A ;
Ricart, W .
CLINICAL CHEMISTRY, 2005, 51 (07) :1201-1205
[8]   Serum ferritin as a component of the insulin resistance syndrome [J].
Fernández-Real, JM ;
Ricart-Engel, W ;
Arroyo, E ;
Balançá, R ;
Casamitjana-Abella, R ;
Cabrero, D ;
Fernández-Castañer, M ;
Soler, J .
DIABETES CARE, 1998, 21 (01) :62-68
[9]   The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES .
ATHEROSCLEROSIS, 2003, 168 (02) :351-358
[10]  
Formiguera X, 1996, MED CLIN-BARCELONA, V107, P782